Step 1 topics → General Pathology → Chemical Mediators of Inflammation

Chemical Mediators of Inflammation

USMLE Step 1 trap: Misattributes histamine release to neutrophils rather than mast cells and basophils. Histamine is stored in and released from mast cells, basophils, and platelets; neutrophils are not a significant source of histamine.

Chemical mediators of inflammation are the molecular signals that coordinate every step of the acute inflammatory response — vasodilation, vascular permeability, leukocyte recruitment, fever, and pain. USMLE Step 1 hits this topic hard because it bridges basic biochemistry with clinical pharmacology: you need to know which mediator does what, where it comes from, and what happens when you block it. The exam tests this at multiple levels — pure recall (which cell releases histamine?), mechanism application (why do NSAIDs reduce fever but not leukotrienes?), and passage-based reasoning where a vignette describes a clinical scenario and asks you to identify the mediator responsible or predict the effect of a drug.

The tricky part is that many mediators have overlapping roles — vasodilation, permeability, fever — and the exam deliberately exploits that overlap. Students often blur the distinctions between cytokines (TNF, IL-1, IL-6, IL-8) or misattribute specific functions to the wrong molecule. The arachidonic acid pathway is a classic trap: students frequently assume NSAIDs block the whole pathway, forgetting that lipoxygenase and leukotrienes are completely untouched. Complement is another landmine — C3a and C5a are both anaphylatoxins, but only C5a is the potent chemotactic signal, and mixing them up is a reliable wrong-answer trap.

To master this for USMLE Step 1, build a function-first mental model: vasodilators (histamine, bradykinin, PGE2, PGI2), chemotaxins (C5a, IL-8, LTB4), fever mediators (IL-1, IL-6, TNF via PGE2), acute-phase inducers (IL-6 dominates), and vascular permeability agents (histamine, bradykinin, leukotrienes C4/D4/E4). Once you map mediators to function — and to cell of origin — the high-yield questions become much more manageable.

From real student decks
49%have cards covering this topic
38%have mature cards

Common misconceptions

Common mistake
Wrong: Histamine in acute inflammation is primarily released by neutrophils.
Right: Histamine is stored in and released from mast cells, basophils, and platelets; neutrophils are not a significant source of histamine.
Neutrophils are recruited to sites of inflammation but do not store or release histamine. Histamine is preformed and stored in granules of mast cells, basophils, and platelets — these are the cells that degranulate rapidly in response to injury, IgE cross-linking, or complement fragments. The confusion likely arises because neutrophils are the dominant cell in acute inflammation, but dominant presence does not mean dominant source of every mediator. Always anchor histamine to mast cells and basophils.
Common mistake
Wrong: TNF-alpha is the primary cytokine responsible for stimulating hepatic acute-phase protein synthesis.
Right: IL-6 is the dominant stimulus for hepatic acute-phase protein production (fibrinogen, CRP, hepcidin), while TNF-alpha and IL-1 primarily mediate fever, endothelial activation, and systemic effects.
TNF-alpha and IL-1 are powerful pro-inflammatory cytokines that drive fever, endothelial activation, and promote IL-6 production — but it is IL-6 that acts on hepatocytes to drive acute-phase protein synthesis (CRP, fibrinogen, hepcidin, serum amyloid A). Think of TNF and IL-1 as the early alarm signals and IL-6 as the downstream effector for liver responses. On USMLE Step 1, if a question asks which cytokine elevates CRP or fibrinogen, the answer is IL-6, not TNF.
Common mistake
Wrong: NSAIDs block both the cyclooxygenase and lipoxygenase pathways of arachidonic acid metabolism.
Right: NSAIDs selectively inhibit cyclooxygenase (COX-1 and COX-2), blocking prostaglandin and thromboxane synthesis, but do not inhibit lipoxygenase or leukotriene production.
NSAIDs work by covalently or competitively inhibiting cyclooxygenase (COX-1 and COX-2), the enzyme that converts arachidonic acid into prostaglandins and thromboxanes. The lipoxygenase pathway — which produces LTB4, LTC4, LTD4, and LTE4 — is a completely separate branch of arachidonic acid metabolism and is unaffected by NSAIDs. This is clinically important: aspirin-exacerbated respiratory disease occurs partly because blocking COX shunts more arachidonic acid into the lipoxygenase pathway, increasing leukotriene production. Zileuton and montelukast are the drugs that target the lipoxygenase pathway.
Common mistake
Wrong: C3a is the complement fragment primarily responsible for neutrophil chemotaxis.
Right: C5a is the most potent complement-derived chemotactic factor for neutrophils and also acts as an anaphylatoxin; C3a is an anaphylatoxin but is a weaker chemotactic signal.
Both C3a and C5a are anaphylatoxins that trigger mast cell degranulation and increase vascular permeability, which is why they're easy to confuse. However, C5a is the far more potent chemotactic agent — it directly recruits and activates neutrophils at the site of complement activation. C3a has minimal chemotactic activity. A useful mnemonic: C5a does Five things — chemotaxis, mast cell degranulation, increased permeability, neutrophil activation, and opsonization setup — while C3a is mostly limited to the anaphylatoxin role.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Which specific mediators cause vasodilation and increased vascular permeability, and which cell types release them — expect questions linking histamine/bradykinin/PGE2 to early vascular changes in acute inflammation.
  2. Which signals are chemotactic for neutrophils versus eosinophils — the exam distinguishes C5a, IL-8, and LTB4 (neutrophils) from IL-5 and eotaxin (eosinophils), and expects you to pick the right one from a list.
  3. The distinct roles of TNF-alpha, IL-1, IL-6, IL-8, and IL-12 — the exam exploits overlap between these cytokines, especially who drives fever, who drives acute-phase proteins, and who recruits neutrophils.
  4. How prostaglandins mediate pain and fever, and exactly which step NSAIDs inhibit in the arachidonic acid cascade — including what NSAIDs do NOT block (lipoxygenase, leukotrienes).

Can you avoid these mistakes?

A patient develops urticaria and bronchospasm minutes after a bee sting. Which cell type is the primary source of the vasoactive mediator responsible for the immediate wheal-and-flare reaction, and what is the mediator?
A researcher blocks cyclooxygenase in an in vitro inflammatory model. Which downstream products are reduced, and which arachidonic acid metabolites remain unaffected? What drug class does this mimic, and what is its clinical implication for asthma?
A patient with bacterial sepsis has markedly elevated CRP and fibrinogen. A medical student attributes this to TNF-alpha acting directly on the liver. What is wrong with this model, and which cytokine is actually responsible for hepatic acute-phase protein synthesis?
An allergist is treating two patients: one with allergic bronchospasm and blood eosinophilia, another with a neutrophil-rich abscess. From the mediator list C3a, C5a, IL-8, LTB4, and IL-5, identify which are primarily chemotactic for neutrophils and which is most relevant for the eosinophilic patient. Which single complement fragment is the most potent neutrophil chemoattractant, and how does it differ from C3a in that regard?

Related topics

Acute Inflammation (Cardinal Signs, Vascular Changes, Leukocyte Recruitment) Reversible vs Irreversible Cell Injury Types of Necrosis Apoptosis (Intrinsic and Extrinsic Pathways) Cell Adaptations (Atrophy, Hypertrophy, Hyperplasia, Metaplasia, Dysplasia)

See how your Anki deck covers this topic.

Upload your deck for a free audit →